Page 10 - Merck Sharp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Head-To-Head Comparison: Dynavax Technologies (NASDAQ:DVAX) & Janux Therapeutics (NASDAQ:JANX)

Head-To-Head Comparison: Dynavax Technologies (NASDAQ:DVAX) & Janux Therapeutics (NASDAQ:JANX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongSan diegoBio farmaImmunomodulators tracirDynavax technologieEngagers tractrMerck sharp dohme corpClover biopharmaceuticals hong kong coDynavax technologies corporationDouble helix corporationZhejiang clover biopharmaceuticals incSerum institute of india pvtJanux therapeutics incValneva scotlandHeplisavb dynavax technologies corporation

Most RA Patients Meet EMA s JAK Inhibitor Warning Criteria

Recent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK inhibitors unless there is no other alternative.

Newcastle upon tyneUnited kingdomGlasgow cityBristol myers squibbKen bakerPeter taylorEli lillySamsung bioepisNorman collissonMaya buchPaul emeryIain mcinnesBritish society for rheumatologyDrug administrationLeeds biomedical research centreUniversity of manchester

PDS Biotechnology Announces Details of Virtual KOL Event

PDS Biotechnology Announces Details of Virtual KOL Event
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

University of north carolinaNorth carolinaUnited statesNew yorkDana farber cancer instituteUniversity of marylandSaint josephGina mangiaracinaMike moyerJared weissKirk shepardRobert haddadAmerican association for cancer researchNeck society meetingLung cancer initiative of north carolinaBiotechnology corporation

Moderna, Inc : Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates

Moderna, Inc : Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomChris ridleySanofi pasteurLavina talukdarMerck keytrudaBlackstone life sciencesLinkedin top companiesMerck sharp dohme corpExchange commissionModerna incDevelopment expensesEuropean unionMinistry of healthEu health emergencyResponse authorityCompany accolade

Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates

Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 expected product sales of approximately $4 billionInitiated three new clinical studies evaluating Moderna's investigational.

United kingdomLavina talukdarMerck keytrudaChris ridleySanofi pasteurResponse authorityCompany accoladeEu health emergencyMinistry of healthEuropean unionDevelopment expensesModerna incExchange commissionMerck sharp dohme corpLinkedin top companiesBlackstone life sciences